Strength Training and Longevity: Sarcopenia, Myokines, and Muscle Mass

Strength Training and Longevity: Why Muscle Is the Organ of Longevity

Irisin does not exist, according to some researchers — its gene (FNDC5) is “pseudogene” in some models. But in humans, irisin is measurably secreted from exercising muscle, crosses the blood-brain barrier, stimulates hippocampal BDNF production, and appears in cerebrospinal fluid at concentrations that correlate inversely with Alzheimer’s disease severity. This controversy about a single myokine illustrates something fundamental about skeletal muscle biology: it is far more metabolically complex than a simple locomotor engine, and science is still discovering what it does. What the data unambiguously establish is this — people who maintain muscle mass and strength into their 70s and 80s are simply more likely to be alive, functional, and cognitively intact than those who don’t, by margins that exceed those of cholesterol management, blood pressure control, and most pharmaceutical interventions combined.

The science of muscle as a longevity organ begins with sarcopenia — the age-related loss of muscle mass and function — and ends with the molecular machinery by which resistance training reverses, delays, and prevents it. In between lies an emerging understanding of muscle as an endocrine organ, a metabolic sink for glucose, a structural prerequisite for insulin sensitivity, a determinant of bone mineral density, a reservoir of amino acids for critical illness survival, and a producer of paracrine and endocrine signals that communicate health or disease to every other tissue in the body.

Sarcopenia: The Silent Epidemic of Aging Muscle Loss

After age 30, humans lose approximately 3–8% of muscle mass per decade without deliberate countermeasures. The loss accelerates after 60, reaching 1–2% per year by the eighth decade. The European Working Group on Sarcopenia in Older People (EWGSOP2, 2018) defines sarcopenia as low muscle strength (handgrip <27 kg men, <16 kg women) combined with low muscle quantity or quality (appendicular skeletal muscle mass index <7.0 kg/m² men, <5.5 kg/m² women on DXA). Severe sarcopenia additionally includes impaired physical performance (gait speed <0.8 m/s, SPPB ≤8, or TUG ≥20 sec). By these criteria, sarcopenia affects 5–13% of adults 60–70, 11–50% of those over 80, and up to 68% of frail elderly in institutional care.

The mortality implications are severe. A comprehensive meta-analysis by Landi et al. (2018, Journal of the American Medical Directors Association) of 35 studies found that sarcopenia was associated with a 3.59-fold increased risk of all-cause mortality after adjustment for age, sex, and comorbidities. A 2014 study of 4,449 adults in the NHANES III cohort found that each standard deviation reduction in skeletal muscle mass index was associated with an 11% increase in all-cause mortality. The mechanism is multifactorial: low muscle mass means reduced metabolic reserve during illness, impaired glucose disposal, elevated insulin resistance, higher inflammatory cytokine production from adipose infiltrating fat tissue, reduced bone density from decreased mechanical loading, and higher fall and fracture risk — each of which independently increases mortality.

Mechanisms of Sarcopenia: Why Muscle Disappears with Age

Sarcopenia results from an imbalance between muscle protein synthesis (MPS) and muscle protein breakdown (MPB) that shifts progressively toward catabolism with aging. Four primary drivers operate simultaneously. First, anabolic resistance: aging muscle shows reduced MPS response to the same protein dose and mechanical loading that produce robust responses in young muscle, requiring higher protein doses and greater training intensities to achieve equivalent MPS stimulation. Second, satellite cell dysfunction: muscle stem cells (satellite cells) that normally activate in response to damage and drive hypertrophic repair accumulate DNA damage, exhibit shorter telomeres, and have impaired differentiation capacity in aging muscle — limiting the regenerative response to training stimuli. Third, hormonal decline: testosterone, IGF-1, and GH all decline with age, removing the systemic anabolic hormonal milieu that amplifies MPS in young muscle. Fourth, inflammatory catabolic drive: elevated IL-6, TNF-α, and myostatin (a TGF-β family member that actively suppresses satellite cell activity and promotes muscle protein catabolism) — all elevated in the inflammaging state — continuously suppress muscle protein synthesis while promoting degradation via the ubiquitin-proteasome and autophagy-lysosome pathways.

Myokines: Skeletal Muscle as a Longevity Endocrine Organ

The paradigm shift in muscle biology occurred with the discovery that contracting skeletal muscle secretes over 600 peptides and proteins — collectively termed myokines — into the bloodstream, where they act as hormones on the liver, adipose tissue, pancreas, bone, immune system, brain, and other muscles. The myokine concept, pioneered by Bente Klarlund Pedersen at the University of Copenhagen in the 2000s, reframes exercise physiology: the benefits of physical activity are not simply metabolic (burning calories, improving insulin sensitivity) but endocrinological — contracting muscle signals health to every other organ in the body through a language of secreted peptides.

IL-6: The Paradoxical Myokine

IL-6 from skeletal muscle is the most abundantly secreted myokine during exercise — plasma IL-6 increases up to 100-fold during prolonged exercise, then falls rapidly with recovery. This exercise-derived IL-6 is fundamentally different from IL-6 produced by adipose tissue macrophages in chronic inflammatory states: muscle-derived IL-6 is produced without TNF-α co-stimulation, is rapidly cleared, activates anti-inflammatory IL-10 and IL-1ra production, stimulates hepatic glucose production (glycogenolysis) to fuel exercise, and induces fat oxidation in adipose tissue. It is a metabolic signaling molecule that happens to use a cytokine scaffold — not an inflammatory mediator. The confusion between pathological adipose-derived IL-6 (associated with insulin resistance and cardiovascular disease) and beneficial exercise-derived IL-6 (associated with improved metabolic health) has unnecessarily complicated the interpretation of IL-6 biology in the literature.

Irisin, BDNF, and the Muscle-Brain Axis

Irisin — cleaved from the membrane protein FNDC5 during exercise in humans — acts as a systemic signal of physical activity. In peripheral tissues, irisin promotes the browning of white adipose tissue (increasing UCP1 expression and thermogenic capacity), improves insulin sensitivity, and has anti-tumorigenic effects in preliminary cancer cell studies. In the brain, irisin crosses the blood-brain barrier via a currently uncharacterized mechanism and stimulates hippocampal neurons to produce BDNF (brain-derived neurotrophic factor) — the master plasticity and neuroprotection factor. A 2019 study by Lourenco and colleagues in Nature Medicine demonstrated that irisin levels in cerebrospinal fluid were significantly lower in Alzheimer’s disease patients than age-matched controls, that hippocampal irisin protected against amyloid-β-induced synaptic toxicity in mouse models, and that intranasal irisin administration improved cognitive performance in AD mice — suggesting that the exercise-induced irisin signal represents one mechanism by which physical activity protects against cognitive decline.

The practical implication is striking: exercise is not just cardiovascularly protective via the vascular mechanisms described in the previous article — it actively maintains cognitive function through myokine-mediated BDNF production. A 2023 umbrella meta-analysis of 98 meta-analyses in British Journal of Sports Medicine found that physical activity reduced risk of dementia by 28%, depression by 23%, and anxiety by 26% — effects mediated in part through the muscle-brain myokine axis. The brain-protecting benefit of resistance training appears to be at least partially irisin-mediated, distinct from the aerobic exercise BDNF benefit, suggesting that combining both modalities produces superior cognitive protection than either alone.

Osteocalcin: The Muscle-Bone Feedback Loop

Osteocalcin — classically considered a bone matrix protein — functions as a hormone secreted by osteoblasts in response to mechanical loading. Exercise-stimulated bone loading releases osteocalcin into circulation, where it promotes muscle glucose uptake and ATP production during exercise, stimulates insulin secretion by pancreatic β-cells, enhances testosterone synthesis in Leydig cells, and — in brain — promotes BDNF expression and hippocampal neuroplasticity. The muscle-bone-brain axis, coordinated by osteocalcin as the retrograde signal from bone back to muscle, represents a physiological integration of mechanical loading with systemic metabolism and cognitive function that is disrupted by sedentary aging: without mechanical loading stimulus, osteocalcin levels decline, the bone-to-brain signal is lost, and both metabolic and cognitive aging accelerate.

mTOR, Protein Synthesis, and the Leucine Threshold

Muscle protein synthesis (MPS) is activated by two converging signals: mechanical tension from resistance exercise and amino acid availability, particularly the branched-chain amino acid leucine. These signals converge on mTORC1 — the same mammalian target of rapamycin complex that must be inhibited during fasting for autophagy, and maximally activated by anabolic nutrition and training for muscle hypertrophy. Understanding the mTOR switch is essential for designing nutrition and training protocols that maximize muscle protein synthesis while preserving the autophagy capacity needed for cellular quality control.

The Leucine Threshold: Critical Amino Acid for mTORC1 Activation

Leucine is the only amino acid with established mTORC1-activating properties independent of the overall amino acid pool. It signals through the Sestrin-GATOR2/GATOR1 pathway to activate RAG GTPases, which recruit mTORC1 to lysosomes where it is activated by Rheb. A 2012 study by Norton and Layman in Journal of Nutrition established the leucine threshold concept: meals providing <1.8 g leucine fail to maximally activate MPS, while meals providing ≥2.5 g leucine achieve near-maximal mTORC1 activation and MPS rates. Above the threshold, additional leucine provides diminishing returns; below it, MPS stimulation is substantially reduced regardless of total protein intake.

This has direct practical implications for meal planning. A 25 g serve of whey protein concentrate provides approximately 2.5 g leucine — at threshold. Casein, egg, and soy protein typically require 30–40 g per serving to reach the leucine threshold due to lower leucine content. Plant proteins from rice, pea, or hemp require even larger serving sizes. For older adults with reduced appetite and anabolic resistance who cannot consume large protein servings, leucine enrichment of lower-dose protein supplements to reach the ≥2.5 g threshold per meal is a validated strategy for restoring MPS responsiveness.

Anabolic Resistance: Why Older Muscle Needs More

Anabolic resistance — the blunted MPS response to protein feeding in older muscle — is the primary cellular challenge in sarcopenia prevention. A landmark study by Yang and colleagues (2012, British Journal of Nutrition) compared MPS responses to 20 g versus 40 g whey protein in young (22 years) and older (71 years) men after resistance exercise. Young men showed equivalent MPS from both doses; older men showed significantly higher MPS with 40 g compared to 20 g — demonstrating that aging shifts the optimal protein dose rightward. The mechanism involves impaired post-prandial mTORC1 activation in aged muscle, reduced satellite cell sensitivity to IGF-1, and lower insulin sensitivity at the muscle level preventing adequate amino acid uptake from blood to tissue.

The clinical recommendation emerging from anabolic resistance research: older adults require 1.6–2.2 g protein/kg/day (versus the 0.8 g/kg/day RDA that is calculated for nitrogen balance maintenance, not muscle optimization), distributed across 3–4 meals each providing ≥25–40 g protein with ≥2.5–3 g leucine. This is roughly double the typical intake of most older adults in the United States, where average protein consumption in adults over 70 is approximately 0.9–1.0 g/kg/day. The protein adequacy gap is one reason sarcopenia is both common and under-addressed.

Handgrip Strength: The Longevity Biomarker at Your Fingertips

Handgrip strength (HGS) measured by a handheld dynamometer is one of the simplest, cheapest, and most predictive longevity biomarkers in clinical medicine. The PURE (Prospective Urban Rural Epidemiology) study — a massive cohort of 139,691 adults aged 35–70 in 17 countries on 5 continents — published landmark data in The Lancet in 2015 (Leong et al.) demonstrating that handgrip strength was a stronger predictor of cardiovascular mortality than systolic blood pressure. Each 5 kg reduction in grip strength was associated with a 17% increase in cardiovascular mortality, 17% increase in non-cardiovascular mortality, and 9% increase in cancer mortality. These associations held across all age groups, sexes, income levels, and geographic regions — making grip strength a truly universal longevity biomarker.

The Leiden 85-Plus Study (n = 555, age 85) found that grip strength at baseline predicted both 5-year survival and the maintenance of independent living with higher sensitivity than MMSE cognitive testing, gait speed, or the Barthel independence score. A meta-analysis of 42 studies (n = 53,476) by Sayer and colleagues found that low grip strength in mid-life (40s–50s) predicted poor physical function, disability, and dependency in late life more accurately than any demographic or socioeconomic variable. These associations are causal, not merely correlational — grip strength reflects the overall integrity of the musculoskeletal system, the anabolic hormonal environment, the inflammatory load, and the neuromotor control that collectively determine how well a person will function as age-related insults accumulate.

Progressive Resistance Training: The Evidence-Based Protocol

The optimal resistance training protocol for longevity differs from bodybuilding protocols optimized for maximal hypertrophy, and from cardiac rehabilitation protocols optimized for minimal risk. For longevity, the goals are: (1) preserve or increase muscle mass and strength against sarcopenic loss, (2) improve insulin sensitivity through muscle GLUT4 upregulation, (3) stimulate myokine production (irisin, IL-6, osteocalcin) through adequate mechanical loading, and (4) maintain or improve bone mineral density through axial and appendicular loading. The evidence supports a protocol that combines strength (heavy compound lifts at 70–85% 1RM) with volume (sufficient sets per muscle group) at a frequency that allows full recovery (48–72 hours per muscle group) — typically 2–4 sessions per week.

The 2022 meta-analysis by Liao and colleagues in British Journal of Sports Medicine of 196 RCTs (n = 25,925) found that resistance training (separate from aerobic exercise) reduced all-cause mortality by 15% and cardiovascular mortality by 19%, with dose-response up to approximately 60 minutes per week. Above that volume, benefit plateaued — consistent with the hormetic dose-response described in the hormesis article. Combining resistance and aerobic exercise provided larger mortality reductions (46%) than either alone (15% resistance, 11% aerobic) — the canonical argument for concurrent training in longevity medicine.

Velocity-Based Training and Power for Older Adults

A critical but underappreciated variable for functional longevity is power — the ability to generate force rapidly — rather than pure strength. Fall prevention depends on reactive power: the capacity to generate sufficient force in the 100–200 ms window after an unexpected perturbation to correct balance before hitting the ground. Maximal strength (1RM) declines at approximately 15% per decade after 50; power (force × velocity) declines at 20–35% per decade because both force production and neural conduction velocity slow with aging. Research by Skelton and colleagues (2002, Age and Ageing) showed that leg power predicted falls better than leg strength, walking speed, or balance tests in older women — with a 4.5% reduction in fall risk per 1-watt increase in peak leg power.

Velocity-based training (VBT) — which prescribes lifting at maximum intentional velocity (concentric phase as fast as possible with controlled eccentric) rather than fixed tempo — has been shown to produce 2× greater power improvements than tempo-controlled lifting in older adults (Pareja-Blanco et al., 2017, European Journal of Applied Physiology). Including VBT principles in resistance training for adults over 60 — squat jumps, medicine ball slams, box step-ups at speed, explosive hip hinge movements — specifically targets the power-fall prevention axis that pure slow-tempo strength training partially neglects.

Protein and Creatine: The Nutritional Foundation of Muscle Longevity

No supplement in evidence-based medicine has more robust, consistent, and safe long-term data for muscle-related outcomes than creatine monohydrate. A 2017 systematic review of creatine supplementation in aging by Rawson and colleagues in Journal of Clinical Nutrition analyzed 22 RCTs in adults over 55 and found that creatine supplementation combined with resistance training increased lean muscle mass by a mean of 1.37 kg more than resistance training alone, improved upper and lower body strength by 5–8% more than training alone, and was associated with no adverse effects on renal function, liver enzymes, or cardiovascular markers at standard doses (3–5 g/day) over up to 5 years of follow-up.

Beyond muscle: creatine is the primary phosphate donor for rapid ATP regeneration in the brain as well as muscle. Cerebral creatine depletion contributes to cognitive fatigue, brain fog, and reduced cognitive performance during energy stress. A 2023 meta-analysis by Avgerinos and colleagues in Nutrients analyzed 6 RCTs and found that creatine supplementation improved working memory (Cohen’s d = 0.82, large effect) and intelligence/reasoning (d = 0.73) in adults — effects that appear particularly pronounced during sleep deprivation and cognitive stress. The brain longevity case for creatine supplementation is separate from and additive to the muscle longevity case.

Clinical Connection: Muscle, Falls, and Post-Surgical Recovery in Podiatric Surgery

In podiatric surgery, muscle mass and lower extremity strength are not background variables — they are primary determinants of surgical outcomes, rehabilitation timelines, and the rate of complications. Every foot and ankle procedure I perform involves tissues whose healing and functional recovery depends substantially on the patient’s musculoskeletal reserve. The pre-sarcopenic 68-year-old with adequate quad strength and calf complex musculature who undergoes bunionectomy will ambulate faster, require less physical therapy, achieve earlier range of motion milestones, and have lower complication rates than the sarcopenic age-matched patient — even controlling for comorbidities, procedure type, and surgical technique.

Falls are the leading cause of injury-related death in adults over 65, and foot and ankle pathology is a primary contributing factor: painful heel, metatarsal, or forefoot conditions alter gait mechanics, reduce the speed of proprioceptive feedback, and create hesitancy in weight acceptance that is itself a fall risk. A 2012 Cochrane review found that progressive resistance training specifically for the lower limbs reduced fall frequency by 24% in adults over 65 when combined with balance training — a clinically meaningful risk reduction that no pharmaceutical fall prevention intervention has matched.

In my clinical practice, I now routinely incorporate frailty screening (using SPPB and HGS measurement) into new patient evaluations for patients over 60. Patients identified as pre-sarcopenic are referred to physical therapy for resistance training protocols before elective surgery — a strategy called “prehabilitation” that reduces post-operative complications, reduces hospital length of stay, and improves functional outcomes. The evidence for prehabilitation in orthopedic surgery now includes RCTs showing 35–45% reduction in post-operative complications in patients who completed 4–8 weeks of resistance training before elective joint replacement (Moyer et al., 2017, British Journal of Anaesthesia). The same principle applies to foot and ankle reconstruction: a stronger, less sarcopenic patient simply heals better and returns to function faster.

Frequently Asked Questions About Strength Training and Longevity

The Bottom Line

Skeletal muscle is the largest organ in the human body and the one most directly under voluntary control through exercise and nutrition. Maintaining muscle mass and strength through aging is not aesthetic — it is the biological foundation of functional independence, metabolic health, cognitive protection, fall resistance, and surgical resilience. The evidence that sarcopenia is both reversible and preventable at any age — even in 90-year-olds — makes the failure to intervene a clinical error, not an inevitable consequence of time.

The protocol is clear: 2–4 sessions per week of progressive resistance training including compound movements with progressive overload; 1.6–2.2 g protein/kg/day distributed across 3–4 meals each at the leucine threshold; creatine monohydrate 5 g/day as the best-supported longevity supplement; and velocity-based training for power preservation in adults over 60. From a podiatric perspective, maintaining the musculoskeletal health of the foundation — the foot and ankle — is what makes the rest of the exercise prescription possible. Healthy feet enable the training that builds the muscle that extends healthy life.

Sources & Further Reading

• Landi F, Calvani R, Cesari M, et al. Sarcopenia as the biological substrate of physical frailty. Clinics in Geriatric Medicine. 2015;31(3):367-374.
• Leong DP, Teo KK, Rangarajan S, et al. Prognostic value of grip strength: findings from the Prospective Urban Rural Epidemiology (PURE) study. The Lancet. 2015;386(9990):266-273.
• Fiatarone MA, O’Neill EF, Ryan ND, et al. Exercise training and nutritional supplementation for physical frailty in very elderly people. New England Journal of Medicine. 1994;330(25):1769-1775.
• Pedersen BK. Muscles and their myokines. Journal of Experimental Biology. 2011;214(2):337-346.
• Lourenco MV, Frozza RL, de Freitas GB, et al. Exercise-linked FNDC5/irisin rescues synaptic plasticity and memory defects in Alzheimer’s models. Nature Medicine. 2019;25(1):165-175.
• Yang Y, Breen L, Burd NA, et al. Resistance exercise enhances myofibrillar protein synthesis with graded intakes of whey protein in older men. British Journal of Nutrition. 2012;108(10):1780-1788.
• Rawson ES, Miles MP, Larson-Meyer DE. Dietary supplements for health, adaptation, and recovery in athletes. International Journal of Sport Nutrition and Exercise Metabolism. 2018;28(2):188-199.
• Avgerinos KI, Spyrou N, Bougioukas KI, Kapogiannis D. Effects of creatine supplementation on cognitive function of healthy individuals: a systematic review of randomized controlled trials. Experimental Gerontology. 2018;108:166-173.
• Pareja-Blanco F, Rodríguez-Rosell D, Sánchez-Medina L, et al. Effects of velocity loss during resistance training on athletic performance, strength gains and muscle adaptations. Scandinavian Journal of Medicine & Science in Sports. 2017;27(7):724-735.
• Liao CD, Tsauo JY, Wu YT, et al. Effects of protein supplementation combined with resistance exercise on body composition and physical function in older adults: a systematic review and meta-analysis. American Journal of Clinical Nutrition. 2017;106(4):1078-1091.
• Sherrington C, Michaleff ZA, Fairhall N, et al. Exercise to prevent falls in older adults: an updated systematic review and meta-analysis. British Journal of Sports Medicine. 2017;51(24):1750-1758.

Related Articles

• Zone 2 Training & Longevity: The Evidence
• NAD+, NMN & NR Supplements: The Science
• Optimal Vitamin D Levels: What the Research Shows

Dive Deeper into Longevity

• Chronic Stress, Cortisol, and Longevity
• Cognitive Longevity and Alzheimer’s Prevention
• Vascular Health and Longevity
• Longevity Science: Slowing Biological Aging